Trevi Therapeutics, Inc. TRVI Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s common stock?
- Trevi Therapeutics, Inc. (TRVI) reported common stock of $128K in Q1 2026.
- How has Trevi Therapeutics, Inc.'s common stock changed year-over-year?
- Trevi Therapeutics, Inc.'s common stock increased by 28.0% year-over-year, from $100K to $128K.
- What is the long-term trend for Trevi Therapeutics, Inc.'s common stock?
- Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s common stock has grown at a 46.5% compound annual growth rate (CAGR), from $19K to $128K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).